BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34093819)

  • 1. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.
    Jia YY; Yu Y; Li HJ
    J Cancer; 2021; 12(14):4183-4195. PubMed ID: 34093819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
    Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
    Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
    Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].
    Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):573-579. PubMed ID: 31434447
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
    Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma.
    Chen M; Zheng SH; Liu Y; Shi J; Qi ST
    J Neurol Sci; 2016 Jan; 360():49-54. PubMed ID: 26723972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway.
    Zheng QM; Lu JJ; Zhao J; Wei X; Wang L; Liu PS
    Biomed Res Int; 2016; 2016():9842619. PubMed ID: 27034956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma.
    Chen L; Tian X; Gong W; Sun B; Li G; Liu D; Guo P; He Y; Chen Z; Xia Y; Song T; Guo H
    Cancer Biol Med; 2019 Feb; 16(1):89-100. PubMed ID: 31119049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.
    Miao C; Liang C; Tian Y; Xu A; Zhu J; Zhao K; Zhang J; Hua Y; Liu S; Dong H; Zhang C; Su S; Li P; Qin C; Wang Z
    Oncotarget; 2017 Nov; 8(58):97811-97821. PubMed ID: 29228653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
    Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
    Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin promotes migration and invasion of renal cell carcinoma through the integrin/focal adhesion kinase/c-Jun N-terminal kinase pathway.
    Chuanyu S; Yuqing Z; Chong X; Guowei X; Xiaojun Z
    Tumour Biol; 2017 Apr; 39(4):1010428317694549. PubMed ID: 28381189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3β signaling pathway in renal cell cancer.
    Peng D; Hu Z; Wei X; Ke X; Shen Y; Zeng X
    IUBMB Life; 2019 Jan; 71(1):113-124. PubMed ID: 30281919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma.
    Chen Z; Zhang Y; Wu X; Zhang J; Xu W; Shen C; Zheng B
    Onco Targets Ther; 2021; 14():2941-2952. PubMed ID: 33976552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.